Papers - KITAMURA Kazuo
-
Glucose metabolism in macrophages contributes to the development of atherosclerosis in apolipoprotein E knockout ... Reviewed
カク異琳、鶴田敏博、関田陽子、坂元紀陽、畠山金太、浅田祐士郎、北村和雄
日本内分泌学会雑誌 89 ( 2 ) 756 - 756 2013
Publishing type：Research paper (scientific journal)
-
産褥期発症の特発性冠動脈解離による急性心筋梗塞に対して冠動脈ステント留置術を行った1例 Reviewed
和田美沙、鬼塚久充、久保恵是、井手口武史、川越純志、鶴田敏博、石川哲憲、今村卓郎、古田賢、古川誠志、鮫島浩、北村和雄
心臓 45 ( 12 ) 1577 - 1583 2013
Publishing type：Research paper (scientific journal)
-
ヒト尿中に存在する主要アンジオテンシン関連ペプチド「Big angiotensin-25」の単離・同定 Reviewed
北村和雄、永田さやか
日本内分泌学会雑誌 89 ( 2 ) 720 - 720 2013
Publishing type：Research paper (scientific journal)
-
アドレノメデュリンの展開研究 Reviewed
北村和雄
心臓 45 ( 12 ) 1496 - 1502 2013
Publishing type：Research paper (scientific journal)
-
心房性ナトリウム利尿ペプチドが発見されるのを見ていて感じたこと Reviewed
北村和雄
心臓 45 ( 5 ) 491 - 491 2013
Publishing type：Research paper (scientific journal)
-
降圧因子"アドレノメデュリン"の研究 Reviewed
北村和雄
血圧 20 ( 1 ) 155 - 155 2013
Publishing type：Research paper (scientific journal)
-
動脈硬化バイオマーカー測定とその臨床的意義 CRP, SAA, ペントラキシン3 Reviewed
石川哲憲、今村卓郎、浅田祐士郎、北村和雄
日本臨牀 71 ( 3 ) 444 - 449 2013
Publishing type：Research paper (scientific journal)
-
Adrenomedullin does not contribute toward the development of abdominal aortic aneurysm in mice Reviewed
坂元紀陽、鶴田敏博、畠山金太、下澤達雄、浅田祐士郎、北村和雄
日本内分泌学会雑誌 89 ( 2 ) 747 - 747 2013
Publishing type：Research paper (scientific journal)
-
2つのアドレノメデュリン受容体のユニークな活性化機構 Reviewed
桑迫健二、北村和雄、永田さやか、加藤丈司
日本薬理学会部会（日本薬理学雑誌） 141 ( 3 ) 22 - 22 2013
Publishing type：Research paper (scientific journal)
-
ステロイド依存性ネフローゼ症候群に対するACTH製剤の有効性：古くて新しい治療 Reviewed
菊池正雄、佐藤祐二、北村和雄、藤元昭一
日本内分泌学会雑誌 89 ( 2 ) 759 - 759 2013
Publishing type：Research paper (scientific journal)
-
肥満の有無による降圧併用療法の効果およびアルドステロン濃度変化の差異 Reviewed
加藤丈司、桑迫健二、北俊弘、北村和雄
日本内分泌学会雑誌 89 ( 1 ) 342 - 342 2013
Publishing type：Research paper (scientific journal)
-
アドレノメデュリンを用いた潰瘍性大腸炎に対する新規治療薬の開発 Reviewed
芦塚伸也、稲津東彦、北俊弘、北村和雄
日本内分泌学会雑誌 89 ( 2 ) 748 - 748 2013
Publishing type：Research paper (scientific journal)
-
潰瘍性大腸炎に対するアドレノメデュリン療法 (続報) Reviewed
芦塚伸也、仮屋暢人、三宮一朗、原口大、三木吾郎、星子新理、松本英丈、中島孝治、稲津東彦、北村和雄
日本消化器病学会雑誌 110 ( suppl-2 ) 933 - 933 2013
Publishing type：Research paper (scientific journal)
-
Advanced diffuse malignant peritoneal mesothelioma responding to palliative chemotherapy Reviewed
Nakashima K., Inatsu H., Kitamura K., Hikosaka T., Hoshiko S., Ashiduka S.
Clinical Journal of Gastroenterology 5 ( 6 ) 373 - 376 2012.12
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Clinical Journal of Gastroenterology
A 64-year-old man diagnosed with advanced malignant peritoneal mesothelioma by laparoscopic biopsy was treated with systemic chemotherapy. The patient underwent first-line chemotherapy with pemetrexed plus cisplatin for 11 months, then second-line chemotherapy with gemcitabine plus vinorelbine for 6 months, and third-line chemotherapy with CPT-11 for 4 months. After third-line chemotherapy failed, he received palliative treatment. Although the tumor continued to grow, and he died 24 months after initiation of treatment, chemotherapy prolonged the survival time and improved his quality of life. © 2012 Springer Japan.
-
Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity. 「"jointly worked"」 Reviewed
Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K
J Am Soc Hypertens 6 ( 6 ) 393 - 398 2012.10
Language：English Publishing type：Research paper (scientific journal)
DOI： 10.1016
-
Usefulness of carotid intima-media thickness measurement as an indicator of generalizedatherosclerosis: findings from autopsy analysis.「"jointly worked"」 Reviewed
Iwakiri?T,?Yano Y,?Sato Y,?Hatakeyama K,?Marutsuka K,?Fujimoto S,?Kitamura K,?Kario K,?Asada Y
Atherosclerosis 225 ( 2 ) 359 - 362 2012.10
Language：English Publishing type：Research paper (scientific journal)
DOI： 10.1016
-
高血圧治療の新戦略?ARB/Ca拮抗薬配合剤をどう使うか?．（共著） Reviewed
北村和雄,横田直人,早田泰英,江藤琢磨,田口利文
Medical Tribune 1 - 4 2012.10
Language：Japanese Publishing type：Research paper (other academic)
-
実地臨床のおける使用成績から、ARB/利尿薬合剤が適した患者像を探る．（共著） Reviewed
北村和雄,浦田秀則,野出孝一
PREMINENT(MSD) 1 - 4 2012.10
Language：Japanese Publishing type：Research paper (other academic)
-
Toida T., Fukudome K., Fujimoto S., Yamada K., Sato Y., Chiyotanda S., Kitamura K.
Clinical Nephrology 78 ( 3 ) 216 - 223 2012.9
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Clinical Nephrology
Background: Lanthanum carbonate (LC) is a non-calcium-containing phosphate binder and shows a comparable effect with other phosphate binders on hyperphosphatemia in dialysis patients. LC also contributes to a reduced oral calcium load compared with calcium carbonate(CaC)treatment. However, no crossover studies which compare the influence on serum calcium level between treatments with LC and CaC in hemodialysis (HD) patients have been carried out. Methods: After washout for 2 weeks, 50 patients on HD were randomized (1 1) to receive LC or CaC for 3 months.Thereafter, patients underwent a second 2-week washout period and were switched to the alternative binder for the next 3 months. Mineral and bone metabolism markers were measured with the changes of vitamin D doses. Results: The serum phosphate level showed a similar decrease from baseline to 3 months in both groups. During the study periods, hypercalcemia was observed only in patients taking CaC. The dose of vitamin D analogue was increased more frequently in the patients of the LC group compared with LC group. The iPTH level showed a significant decrease in the CaC group, but not in the LC group. Serum levels of BAP, TRAP5b, and ALP were significantly elevated in the LC group, whereas the FGF-23 level showed a significant decrease. Conclusion: LC effectively reduced the serum phosphate level (like CaC) and allowed the vitamin D analogue dosage to be increased without hypercalcemia in HD patients. LC is one of the useful phosphate binders without hypercalcemia.(UMIN-CTR registration number:UMIN000002331). © 2012 Dustri-Verlag Dr. K. Feistle.
DOI： 10.5414/CN107257
-
Reprint of “Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma” Reviewed
Kitamura K.
Biochemical and Biophysical Research Communications 425 ( 3 ) 548 - 555 2012.8
Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Biochemical and Biophysical Research Communications